Relationships of obesity and fat distribution with atherothrombotic risk factors: Baseline results from the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial

Obesity

Volumn 18, Issue 5, 2010, Pages 1046-1054

  Albu, Jeanine B ^a   Lu, Jiang ^b   Mooradian, Arshag D ^c   Krone, Ronald J ^d   Nesto, Richard W ^e   Porter, Marty H ^f   Rana, Jamal S ^g   Rogers, William J ^h   Sobel, Burton E ⁱ   Gottlieb, Sheldon H ^j  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^f ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h University of Alabama at Birmingham   (United States)

ⁱ UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^j JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LIFESTYLE; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REGRESSION ANALYSIS; RISK; RISK ASSESSMENT; RISK FACTOR; VASCULAR DISEASE; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY FAT DISTRIBUTION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; REGRESSION ANALYSIS; RISK; RISK ASSESSMENT; RISK FACTORS; VASCULAR DISEASES; WAIST CIRCUMFERENCE;

EID: 77951666272     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.339     Document Type: Article

References (43)

1. Must A, Spadano J, Coakley EH et al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-1529.
2. Zhu S, Wang Z, Heshka S et al. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 2002;76: 743-749.
3. Schneider HJ, Glaesmer H, Klotsche J et al.; DETECT Study Group. Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab 2007;92:589-594.
4. Poirier P, Giles TD, Bray GA et al.; American Heart Association. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898-918.
5. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 2006;113:2943-2946. (Pubitemid 44297236)
6. Klein S, Allison DB, Heymsfield SB et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr 2007;85:1197-1202. (Pubitemid 46740459)
7. Manson JE, Willett WC, Stampfer MJ et al. Body weight and mortality among women. N Engl J Med 1995;333:677-685.
8. Yusuf S, Hawken S, Ounpuu S et al.; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005;366:1640-1649.
9. Adams K F, Schatzkin A, Harris TB et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006;355:763-778.
10. National Heart Lung and Blood Institute (NHLBI) Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. Obes Res 1998;6:51S-209S.
11. Albu J, Gottlieb SH, August P, Nesto RW, Orchard TJ; Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators. Modifications of coronary risk factors. Am J Cardiol 2006;97:41G-52G.
12. Grundy SM, Cleeman JI, Daniels SR et al.; American Heart Association. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.
13. Zoppini G, Verlato G, Leuzinger C et al. Body mass index and the risk of mortality in type II diabetic patients from Verona. Int J Obes Relat Metab Disord 2003;27:281-285. (Pubitemid 36255813)
14. Bruno G, Merletti F, Biggeri A et al.; Casale Monferrato Study. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 2004;27: 2689-2694.
15. Kip KE, Marroquin OC, Kelley DE et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004;109:706-713.
16. Tseng CH. Body mass index and waist circumference as determinants of coronary artery disease in Taiwanese adults with type 2 diabetes mellitus. Int J Obes (Lond) 2006;30:816-821.
17. Hoefle G, Saely CH, Aczel S et al. Impact of total and central obesity on vascular mortality in patients undergoing coronary angiography. Int J Obes (Lond) 2005;29:785-791.
18. Dagenais GR, Yi Q, Mann JF et al. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 2005;149:54-60.
19. Kragelund C, Hassager C, Hildebrandt P, Torp-Pedersen C, Køber L; TRACE study group. Impact of obesity on long-term prognosis following acute myocardial infarction. Int J Cardiol 2005;98:123-131. (Pubitemid 40169862)
20. Uretsky S, Messerli FH, Bangalore S et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007;120: 863-870.
21. Sobel BE. Optimizing cardiovascular outcomes in diabetes mellitus. Am J Med 2007;120:S3-11.
22. Sobel BE; BARI 2D Trial Investigators. Ancillary studies in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial: Synergies and opportunities. Am J Cardiol 2006;97:53G-58G.
23. Eckel RH. Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD. Proc Nutr Soc 2007;66:82-95.
24. Van Gaal L F, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006;444:875-880.
25. Després J P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-887.
26. Kahn HS, Dunbar VG, Ziemer DC, Phillips LS. Diabetes in urban African Americans. XII. Anthropometry for assessing municipal hospital outpatients recently diagnosed with type 2 diabetes. Obes Res 1998;6:238-245.
27. Brooks MM, Frye RL, Genuth S et al.; Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol 2006;97:9G-19G.
28. Frye RL, August P, Brooks MM et al.; BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503-2515.
29. Mozumdar A, Roy SK. Method for estimating body weight in persons with lower-limb amputation and its implication for their nutritional assessment. Am J Clin Nutr 2004;80:868-875
30. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription, 6th edn. Lippincott Williams & Wilkins: Baltimore, MD, 2000.
31. Myers J, Bader D, Madhavan R, Froelicher V. Validation of a specific activity questionnaire to estimate exercise tolerance in patients referred for exercise testing. Am Heart J 2001;142:1041-1046.
32. Kelinbaum DG, Kupper LL, Muller KE, Nizam A. Applied Regression Analysis and Other Multivariable Methods. Duxbury Press, Brooks/Cole Publishing: Pacific Grove, CA,1998.
33. Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 2001;24:1522-1527.
34. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. J Am Med Assoc 2003;289:76-79
35. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Després J P. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 1993;58:463-467.
36. Stanforth PR, Jackson AS, Green JS et al. Generalized abdominal visceral fat prediction models for black and white adults aged 17-65 y: the HERITAGE Family Study. Int J Obes Relat Metab Disord 2004;28:925-932.
37. Brown CD, Higgins M, Donato KA et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000;8:605-619.
38. Liese AD, Hense HW, Döring A, Stieber J, Keil U. Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95. J Hum Hypertens 2001;15: 799-804.
39. Després J P, Lamarche B, Mauriège P et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-957.
40. Kohler H P, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000;342:1792-1801.
41. Meigs JB, Mittleman MA, Nathan DM et al. Hyperinsulinemia, hyperglycemia and impaired hemostasis. The Framingham offspring study. J Am Med Assoc 2000;283:221-228.
42. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy R P. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000;152: 897-907.
43. Thomas F, Bean K, Pannier B et al. Cardiovascular mortality in overweight subjects: the key role of associated risk factors. Hypertension 2005;46: 654-659